What are the available kit sizes?

The kit is available in two sizes: 48 tests or 96 tests per box.

What is the minimum order quantity (MOQ)?

The minimum order quantity is 5 boxes.

What is the lead time for shipping?

Peak season lead time is within 15 workdays, while off-season is one month.

Advanced Human Interleukin Elisa Kit for Research Purposes

Name: Advanced Human Interleukin Elisa Kit for Research Purposes
Brand: Nanjing Mornmed Medical Equipment Co., Ltd.
SKU: 2120986562

Jiangsu, ChinaNanjing Mornmed Medical Equipment Co., Ltd.

US$65.00-98.00

5 boxes

Product specifications

Test

Product profile

Customization

Available

Classification

Scientific Research

Type

Elisa Kit

Model NO.

CK-EA1

Application

Only for Research Use

Samples

48 or 96t

Sample

10UL

Specificity

99.5%

Sensitivity

99.9%

Time

15 Min

MOQ

5 Boxes

Species

Human and Animals Research Use

Transport Package

Standard Export Packing

Trademark

Mornmed

Origin

Jiangsu, China

Production Capacity

10000 Set/Sets Per Month

Key features

High Sensitivity: Achieves 99.9% sensitivity for accurate detection of Human Interleukin.

High Specificity: Ensures 99.5% specificity, minimizing cross-reactivity in results.

Rapid Results: Delivers test results within 15 minutes for efficient workflow.

Versatile Sample Types: Suitable for Human serum, plasma, tissue homogenates, and other biological fluids.

Flexible Kit Sizes: Available in 48 or 96 tests per kit to match your research needs.

Strict Research Use: Designed exclusively for scientific research purposes, not for diagnostic use.

Company profile

Nanjing Mornmed Medical Equipment Co., Ltd.

Jiangsu, China

Business Type: Trading CompanyExport Year: 2019-08-01Nearest Port: Shanghai, Qingdao, YiwuAverage Response Time: ≤2.98hTerms of Payment: T/T, PayPal, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAP, FCA

AI-Powered supplier vetting

SummaryNanjing Mornmed Medical Equipment Co., Ltd. is a China-based trading company in the health and medicine sector, offering medical and surgical equipment and related products. It reports long-term relationships with Chinese manufacturers, more than 10 production lines within its supply network, international export markets, and stated after-sales support. ISO 13485 and ISO 9001 are reported, and an SGS audit was recorded for the period from August 28, 2024 to August 27, 2025, although the audit result is not interpretable from the provided code. Production-scale and delivery claims are stated, but the supplier’s own manufacturing capacity, customization services, innovation systems, overseas service infrastructure, and financial credibility are not sufficiently evidenced. Customer relationships and positive evaluations are claimed, without named customer cases or independently verifiable details.

Supplier typeThe supplier is explicitly identified as a trading company headquartered in Nanjing, China, operating in health and medicine. Its product scope covers medical equipment, surgical equipment, disposables, ENT, dental, scale, and orthopedic products, and it presents itself as an integrated one-stop supplier.

CertificationsISO 13485 and ISO 9001 are reported as supplier management-system certifications. An SGS audit is also recorded, but the provided audit result code cannot establish whether the evaluation was passed or favorable.

After-Sales capabilityThe supplier explicitly states that it provides service and after-sales support and aims to support customers. However, contract-based capacity, inventory service, overseas warehouses, showrooms, agents, and branches are all marked unknown, so the breadth and operational depth of after-sales support cannot be verified.

Production capacityThe supplier reports more than 10 production lines, international export markets, approximately one-month off-peak lead time, and peak-season fulfillment within 15 working days. However, it is classified as a trading company and the stated factory address is separate from the company address, so the slices support supply-network and fulfillment capability more clearly than direct ownership or control of manufacturing assets.

Client casesThe supplier claims established business relationships with customers across Asia, the Middle East, Africa, South America, North America, and Southeast Asia, along with positive customer evaluations. The slices provide no named customers, project descriptions, order references, or independently verifiable case evidence.